Industry news

Share this article:
GlaxoSmithKline is partnering with the Healthcare Communication & Marketing Association (HCMA) to provide education, training and support to members on its Value of Medicine Program, aimed at getting the industry's side out on issues including drug costs, marketing and promotion, drug importation, drug safety and the Medicare prescription drug benefit. “HCMA members hold key marketing and education positions in the industry,” said Jay Bolling, president of HCMA and president of Roska Healthcare Advertising. “This strategic partnership with GSK will provide our members with the tools and information necessary to repair the perception the healthcare profession and patients have of our industry.”
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.